ClinicalTrials.Veeva

Menu

Effect of Left Atrial Ablation on Left Atrial Appendage Emptying Flow Velocity (ABLAA-FV)

N

National and Kapodistrian University of Athens

Status

Unknown

Conditions

Atrial Fibrillation

Treatments

Procedure: Pulmonary vein isolation

Study type

Observational

Funder types

Other

Identifiers

NCT02801175
1/13.6.2016

Details and patient eligibility

About

Consecutive patients with paroxysmal AFib scheduled to undergo pulmonary vein isolation either with radiofrequency (RF) or cryoballoon will be included. Left atrial appendage emptying flow velocity (LAA-EFV) will be measured with transesophageal echocardiography (TEE) immediately before and following left atrial ablation (1 month post). The change in LAA-EFV will be compared between the two groups (RF versus Cryo).

Enrollment

40 estimated patients

Sex

All

Ages

21 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Paroxysmal atrial fibrillation, no absolute contraindication for anticoagulation

Exclusion criteria

Previous cardiac surgery Previous left atrial ablation History of cerebrovascular event Presence of LAA thrombus Inability to provide informed consent

Trial design

40 participants in 2 patient groups

RF
Description:
Patients with paroxysmal atrial fibrillation slated for radiofrequency pulmonary vein isolation
Treatment:
Procedure: Pulmonary vein isolation
Cryoballoon
Description:
Patients with paroxysmal atrial fibrillation slated for cryoballoon pulmonary vein isolation
Treatment:
Procedure: Pulmonary vein isolation

Trial contacts and locations

1

Loading...

Central trial contact

Spyridon Deftereos, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems